# 2025-15156: Curia New York Files for DEA Permission on Controlled Drug Imports

2025-15156, Importer of Controlled Substances Application: Curia New York Inc, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2025-08-11 (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2025-15156
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-15156
- Title: Importer of Controlled Substances Application: Curia New York Inc
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 90 FR 38666
- Published: 2025-08-11
- Effective: unknown
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

Curia New York Files for DEA Permission on Controlled Drug Imports

## Summary

Curia New York Inc wants to become an official importer of certain controlled substances. This means they’ll be allowed to bring in specific drugs that are carefully regulated. If approved, it could impact businesses and researchers who rely on these substances, with timing and money details to watch for in the official info.

## Abstract

Curia New York Inc has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

## Effects PRIA read

- Importer Registration Application Filed: mixed, low. Curia New York Inc has applied to be registered as an importer of certain controlled substances. If their registration is approved, businesses and researchers that rely on those regulated drugs could be affected. The Federal Register notice points readers to supplementary information for which drug…

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2025-15156 on federalregister.gov](https://www.federalregister.gov/documents/2025/08/11/2025-15156/importer-of-controlled-substances-application-curia-new-york-inc)
- [2025-15156 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-08-11/pdf/2025-15156.pdf)

## Related
- [Previous: 2025-15155, Importer of Controlled Substances Application: Galephar Pharmaceutical Research…](https://policyrisk.com/federal-register/2025-15155)
- [Next: 2025-15157, Bulk Manufacturer of Controlled Substances Application: Cambrex Charles City](https://policyrisk.com/federal-register/2025-15157)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-15156 (as of 2026-06-08).